Skip to content

Bio-Techne TECH Ratios & Valuation

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
Profitability
Gross margin65%-0.3pp65.2%-0.2pp65.4%+0.6pp64.8%-1.0pp65.8%+0.1pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio4.5×-0.1×4.5×+0.3×4.2×+0.8×3.5×-0.2×3.7×-0.2×
Leverage
Debt-to-equity0.1×0.0×0.2×0.2×0.0×0.2×0.0×
Per Share
Book value per share$13.25+3.4%$12.81$12.01-5.4%$12.70-1.9%
Valuation
Market capitalization$8.18B-10.8%$9.16B+5.8%$8.66B+10.5%$7.84B-15.4%$9.27B-19.0%
Price / sales6.8×-0.8×7.5×+0.4×7.1×+0.7×6.4×-1.2×7.7×-1.9×
Price / book3.9×-0.6×4.6×4.1×-0.5×4.6×-0.9×
Dividend yield0.6%+0.1pp0.5%0.0pp0.6%-0.1pp0.6%+0.1pp0.5%+0.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bio-Techne's profit margins?
Bio-Techne (TECH) runs a 65.0% gross margin and a 14.2% operating margin, with a 10.9% net margin.
Where do Bio-Techne's ratios come from?
Every ratio is computed from Bio-Techne's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.